Non-denaturing Buffer Isolation of Multi-protein Complexes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to reliably isolate multi-protein complexes in a biologically active form, and existing protein arrays lack the in vivo associations necessary for physiological relevance, particularly for large complexes involved in cell signaling.
Innovation Solution
The development of non-denaturing buffers and methods for isolating multi-protein complexes that retain their native structure and activity, allowing for the immobilization of these complexes on substrates for use in high-throughput screening assays, using specific detergents, reducing agents, buffering agents, chelating agents, and protease inhibitors to maintain protein activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional buffers containing SDS, sodium deoxycholate and/or other detergents are used for immunoprecipitation of protein complexes, then the isolation of protein complexes is achieved, but the activity of the receptor and surrounding proteins (kinases and phosphatases) is altered
Solution Approach 1:
The patent modifies the chemical parameters of the buffer by replacing conventional denaturing detergents (SDS, sodium deoxycholate) with non-denaturing alternatives that maintain protein activity. This parameter change allows the buffer to solubilize membrane proteins while preserving the native conformation and biological activity of receptors, kinases, and phosphatases in the complex
Solution Approach 2:
The patent introduces a specially formulated non-denaturing buffer as an intermediary substance that mediates between the need to solubilize protein complexes for isolation and the need to preserve their biological activity. This buffer acts as a protective medium that enables extraction without denaturation
2Productivity
If proteins are immobilized on a biochip surface to create interaction protein arrays, then screening capability is achieved, but the in vivo co-localization and physiological relevance of protein interactions cannot be guaranteed
Solution Approach 1:
The patent applies preliminary action by pre-assembling complete, biologically active multi-protein complexes in solution under physiological conditions before immobilizing them on the biochip surface. This ensures that the native interactions and spatial relationships within the complexes are established prior to surface attachment, preserving physiological relevance during screening
Solution Approach 2:
The patent creates accurate copies of in vivo protein complexes by isolating them with non-denaturing buffers that maintain their native structure and interactions, then immobilizing these authentic complexes on the biochip. This copying approach preserves the physiological relationships that would otherwise be lost in traditional immobilization methods
Data Source
Figure 1A~1B
Figure 1C~1D
Figure 2A~2D
AI summary
Methods for isolating and using multi-protein complexes that are biologically active are provided. The complexes contain one or more proteins of interest (e.g. a receptor, ion channel, etc.) and associated scaffolding proteins such as phosphatases, kinases and post synaptic density components. Buffers that do not contain denaturing agents and which may be used to isolate the multi-protein complexes are also provided, as are protein arrays containing the biologically active multi-protein complexes. The protein arrays may be used, for example, for high throughput screening assays.